You are here: Industry Insights > Pfizer

News List

Pfizer Unveils $500M Biotech Fund contractpharma
June 03, 2020
New program to support continued biotechnology innovation across a portfolio of clinical-stage biotechnology companies.
Pfizer's Ibrance 'unlikely' to hit key early breast cancer goal pharmatimes
June 02, 2020
Pfizer's bid to develop Ibrance (palbociclib) for a certain form of early breast cancer has hit a critical setback after an early analysis of data concluded that it the drug was unlikely to hit its primary goal.
Pfizer ties up with glass maker Corning for vial supply expresspharma
June 01, 2020
Pfizer, like rivals Merck & Co and AstraZeneca, is racing to develop a vaccine for COVID-19, the illness caused by the novel coronavirus, which does not yet have an approved vaccine or treatment.
NICE final guidance backs Pfizer's Lorviqua pharmatimes
May 13, 2020
The National Institute for Health and Care Excellence (NICE) has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of lung cancer on the NHS.
Pfizer, BioNTech dose first participants in Covid-19 vaccine trial in US pharmaceutical-business-review
May 08, 2020
Pfizer and Biopharmaceutical New Technologies (BioNTech) have dosed the first participants of a phase 1/2 trial for their Covid-19 vaccine candidate BNT162 in the US.
First Patient Dosed With Pfizer’s Potential COVID-19 Vaccine in US europeanpharmaceuticalreview
May 07, 2020
Pfizer and BioNTech have initiated Phase I/II trials in the US to determine the safety and optimal dose of four mRNA COVID-19 vaccine candidates.
Valneva and Pfizer collaborate for Lyme disease vaccine expresspharma
May 04, 2020
VLA15 is the only active Lyme disease vaccine programme in clinical development today, and covers six serotypes that are prevalent in North America and Europe.
Financial Report -Pfizer contractpharma
April 30, 2020
Biopharma revenues up 11% in the quarter to $10.0 billion; generic competition impacts Upjohn revenues.
Germany to begin first clinical trial of COVID-19 vaccine candidate europeanpharmaceuticalreview
April 24, 2020
A Phase I/II clinical trial for BioNTech’s BNT162 vaccine programme to prevent COVID-19 infection has been granted approval in Germany.
EMD Serono, Pfizer Receive Breakthrough Therapy Designation, Submit Application for BAVENCIO americanpharmaceuticalreview
April 15, 2020
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer announced completion of the submission.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page